JP2016522792A5 - - Google Patents

Download PDF

Info

Publication number
JP2016522792A5
JP2016522792A5 JP2016502413A JP2016502413A JP2016522792A5 JP 2016522792 A5 JP2016522792 A5 JP 2016522792A5 JP 2016502413 A JP2016502413 A JP 2016502413A JP 2016502413 A JP2016502413 A JP 2016502413A JP 2016522792 A5 JP2016522792 A5 JP 2016522792A5
Authority
JP
Japan
Prior art keywords
delivery system
drug delivery
transdermal drug
group
sucrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016522792A (ja
JP6391664B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/027357 external-priority patent/WO2014152454A1/en
Publication of JP2016522792A publication Critical patent/JP2016522792A/ja
Publication of JP2016522792A5 publication Critical patent/JP2016522792A5/ja
Application granted granted Critical
Publication of JP6391664B2 publication Critical patent/JP6391664B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502413A 2013-03-15 2014-03-14 リバスチグミンを含む、経皮薬物送達システム Expired - Fee Related JP6391664B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361799015P 2013-03-15 2013-03-15
US61/799,015 2013-03-15
PCT/US2014/027357 WO2014152454A1 (en) 2013-03-15 2014-03-14 Transdermal drug delivery system containing rivastigmine

Publications (3)

Publication Number Publication Date
JP2016522792A JP2016522792A (ja) 2016-08-04
JP2016522792A5 true JP2016522792A5 (enExample) 2017-04-13
JP6391664B2 JP6391664B2 (ja) 2018-09-19

Family

ID=51528077

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502413A Expired - Fee Related JP6391664B2 (ja) 2013-03-15 2014-03-14 リバスチグミンを含む、経皮薬物送達システム

Country Status (10)

Country Link
US (1) US20140271866A1 (enExample)
EP (1) EP2968248A4 (enExample)
JP (1) JP6391664B2 (enExample)
KR (1) KR20160005024A (enExample)
CN (1) CN105263488A (enExample)
AU (1) AU2014239687B2 (enExample)
CA (1) CA2906796A1 (enExample)
HK (1) HK1220109A1 (enExample)
TW (1) TWI635876B (enExample)
WO (1) WO2014152454A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104523656A (zh) * 2014-11-20 2015-04-22 美吉斯制药(厦门)有限公司 一种卡巴拉汀缓释透皮贴剂及其制备方法
CN105693556A (zh) * 2016-03-01 2016-06-22 巴斯特医药科技(常州)有限公司 卡巴拉汀酒石酸盐的转化方法及其产物制成的贴片
AU2017384526B2 (en) 2016-12-20 2023-11-02 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
AU2017384392B2 (en) 2016-12-20 2023-05-25 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
JP2020525545A (ja) 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
US11389421B2 (en) 2017-09-05 2022-07-19 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of rivastigmine
AU2019291060B2 (en) 2018-06-20 2024-09-05 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
US12329862B2 (en) 2018-06-20 2025-06-17 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
KR102710072B1 (ko) * 2018-08-31 2024-09-24 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
CN108926549A (zh) * 2018-09-27 2018-12-04 安徽安科余良卿药业有限公司 卡巴拉汀凝胶贴膏及其制备方法
TWI720366B (zh) 2018-11-16 2021-03-01 得生製藥股份有限公司 經皮吸收貼片
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
AU7324994A (en) * 1993-07-08 1995-02-06 Avery Dennison Corporation Acrylic-saturated rubber hybrid pressure-sensitive adhesives
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
CA2389865A1 (en) * 1999-11-04 2001-05-10 Xel Herbaceuticals Transdermal administration of huperzine
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US7638522B2 (en) * 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
CA2489865C (en) * 2002-06-25 2012-05-08 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
US7516422B2 (en) * 2005-07-21 2009-04-07 International Business Machines Corporation Graphical display of hierarchical hardlinks to files in a file system
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2007066339A1 (en) * 2005-12-07 2007-06-14 Ramot At Tel Aviv University Ltd. Drug-delivering composite structures
WO2009158032A1 (en) * 2008-06-25 2009-12-30 Fe2, Inc. Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
US8440304B2 (en) * 2008-09-16 2013-05-14 Henkel Corporation Acrylic pressure sensitive adhesive formulation and articles comprising same
WO2011034323A2 (en) * 2009-09-16 2011-03-24 Samyang Corporation Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system
JP2012236773A (ja) * 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
NZ605352A (en) * 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
DE102010026903A1 (de) * 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
EP2688561B1 (en) * 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer

Similar Documents

Publication Publication Date Title
JP2016522792A5 (enExample)
JP5680197B2 (ja) ドネペジルを含む経皮吸収製剤
JP6391664B2 (ja) リバスチグミンを含む、経皮薬物送達システム
JP6556873B2 (ja) 経皮吸収製剤
JP2017538735A5 (enExample)
WO2013187451A1 (ja) 貼付剤
RU2014111255A (ru) Трансдермальная терапевтическая система для гидрохлорида 5-аминолевулиновой кислоты
JP2018525419A5 (enExample)
ES2629063T3 (es) Preparación de parche
CN110022864A (zh) 用于治疗睡眠障碍的经皮吸收制剂
JP6457486B2 (ja) 貼付製剤
CN102895217A (zh) 长效多奈哌齐经皮吸收贴剂
CN100508964C (zh) 膏药
JP5930877B2 (ja) 経皮吸収製剤
WO2013133388A1 (ja) 貼付剤
CN113874011B (zh) 外用制剂
JP7495679B2 (ja) ヒトパピローマウイルス性疣贅に対する貼付剤
KR101566817B1 (ko) 케토티펜 또는 그 염을 함유하는 경피흡수제제
CN105232497A (zh) 一种褪黑素(Melatonin)经皮输送制剂的配方组成和制剂体系
CN202052059U (zh) 微孔型透皮贴膜
CN202526619U (zh) 一种贴剂
US20230149322A1 (en) Blonanserin-containing patch and production method therefor
JP2008039618A (ja) しなやかさ測定方法及び貼付剤
HK1180588A (en) Transdermal drug delivery system containing donepezil